Remote Monitoring Found Effective for Glaucoma Treatment

Monday, January 18, 2021 News on IT in Healthcare
Email Print This Page Comment bookmark
Font : A-A+

People with glaucoma and eye doctors face a dilemma. On one hand patients with glaucoma are at high risk of losing their eyesight if their disease progresses undetected and essential therapy adjustments are delayed. On the other hand these typically elderly vulnerable individuals are often hampered in seeing their doctor for office visits particularly during a lockdown.

Clinical study: telehealth glaucoma care

Glaucoma specialists and patients welcome the results of the clinical study published in Ophthalmology Glaucoma (1) – they show how Implandatas EYEMATE system is transforming glaucoma treatment. During a lockdown period eye specialists remotely monitored the intraocular pressure of their patients. Based on data generated by the EYEMATE system doctors changed the therapy of 29% of their patients without requiring an office visit – thus reducing the risk of vision loss and keeping them safe during the lockdown.

What this means for people with glaucoma

Undetected disease progression is a big risk. Glaucoma gradually robs people of their vision. Continual remote monitoring of glaucoma patients allows early therapy adjustment as needed even when glaucoma patients are unable to visit their eye doctor. Thus EYEMATE enables patients and their eye doctors to be informed in real-time of disease progression which means the therapy can be adjusted without delay – before eyesight is permanently lost.

What glaucoma experts say -

Kaweh Mansouri M.D. lead investigator of the study ophthalmologist at Clinique de Montchoisi Lausanne/Switzerland and Professor at the Department of Ophthalmology at University of Colorado explains: "Our study shows that unnecessary clinic visits can be avoided by remote glaucoma monitoring. This is particularly important during the current pandemic for elderly patients who are at highest risk for COVID-19 complications."

Robert N. Weinreb, M.D., Chair and Distinguished Professor of Ophthalmology at University of California, San Diego adds: "The study findings help us envisage a future for tele-ophthalmology in glaucoma management far beyond the COVID-19 pandemic. Remote patient monitoring and management significantly enhance existing glaucoma diagnostics, and allows a more rational application of existing and future vision-saving therapies."



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store